跳至主要内容
临床试验/CTRI/2025/07/090075
CTRI/2025/07/090075尚未招募2/3 期

To assess the efficacy of musta churna on stahulya and its effect on associated inflammatory markers.

Ayurvedic and Unani Tibbia College and Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年1月1日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Assessment of Obesity based on the Questionnaire

研究概览

简要总结

Excess body fat is the characteristics of obesity, a chronic health risk that is becoming more widespread. It appears gradually and frequently lasts a lifetime. In the United States, obesity is second only to smoking as a preventable cause of mortality. Obesity was formerly thought to be linked to wealthy lifestyles in western nations. Nonetheless, obesity is a rapidly expanding issue in emerging nations and is currently linked to heightened health hazards. Numerous research conducted in India have demonstrated a link between the rising risk of metabolic disorders such type 2 diabetes mellitus, hypertension, and dyslipidaemia with changes in dietary patterns, levels of physical activity, and affluent lifestyles.

Obesity affects people of all ages and genders today. Currently, one-third of people on the planet are obese or overweight. Consequently, the treatment is centred on current global issues. According to a review of the literature, there are many different Ayurvedic anti-obesity formulations in the market, however there aren’t many that balance all the tridoshas and reduce obesity. In order to optimise the formulation for the intended therapeutic impact, minimising the drawbacks of earlier literature in this study. Reducing body weight by limiting the absorption of nutrients is one of the treatment approaches.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • obese individuals from both the genders in the age group of
  • 40 years.
  • BMI greater than or equal to 30 kg/m2 and less than or equal to 34.5 Kg/m2.

排除标准

  • Pathophysiologic/ genetic syndromes associated with obesity (Cushing’s syndrome, Turner’s syndrome, Prader willi syndrome).
  • Patients with poorly controlled Hypertension (greater than 160 / 100 mm Hg)
  • Patients on prolonged (greater than 6 weeks) medication with corticosteoids, antidepressants, anticholinergics, etc.
  • H/o hypersensitivity to any of the trial drugs or their ingredients.
  • Choose the patients who were not enrolled in any study within six (06) months of initial visit.
  • DM, Dyslipidemia, Metabolic Disorder.

结局指标

主要结局

Assessment of Obesity based on the Questionnaire

时间窗: post completion of intervention

次要结局

  • assessment of effect on selective biomarkers (inflammatory markers) : IL6, TNF alpha and CRP(90 DAYS)

研究者

发起方
Ayurvedic and Unani Tibbia College and Hospital
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

VAGHELA AJAYBHAI MANUBHAI

Ayurvedic and Unani Tibbia college and Hospital

研究点 (1)

Loading locations...

相似试验

To analyze the effect of an ayurvedic herb in obese... | 临床试验